| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |